Combination of 5-azacytidine and thalido
β
Azra Raza; Murtaza Mehdi; Muhammad Mumtaz; Fahad Ali; Steven Lascher; Naomi Gali
π
Article
π
2008
π
John Wiley and Sons
π
English
β 224 KB
π 1 views
## Abstract ## BACKGROUND. The treatment of myelodysplastic syndromes (MDS) remains a challenge to the clinician despite recent advances. Many patients will either not respond or will have only limited and/or brief responses to singleβagent therapy. Eventually, 30% of patients with MDS will progre